Biosimilars Market Size, Growth & Statistics Report from 2026 to 2035
The global biosimilars market has experienced strong expansion driven by the rising need for affordable biologic therapies. The market was valued at USD 36.08 billion in 2025 and is projected to reach approximately USD 161.93 billion by 2035, registering a compound annual growth rate (CAGR) of 16.2% during the forecast period (2026–2035).
This robust growth trajectory reflects increasing regulatory approvals, patent expirations of blockbuster biologics, and expanding healthcare access across emerging economies.
